The SARS-CoV-2 pandemic inevitably has affected most countries worldwide; however, the impact may vary both between and within countries, partly because of the degree to which control strategies are adopted and executed. The number of laboratory-confirmed cases is fairly high in the United States, China, Europe, Japan, and South Korea in comparison to developing countries. However, this is likely because of the lack of laboratory testing for many suspected and contact cases, weak infrastructures of hospitals and laboratories in many areas, and extremely high population density. These facts render the efficient diagnosis and tracing of infected cases very limited in these countries. In contrast, in Germany alone, about a half million real time RT-PCR (reverse transcription polymerase chain reaction) tests are performed per week.